Literature DB >> 11115850

Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.

E Serra1, T Rosenbaum, U Winner, R Aledo, E Ars, X Estivill, H G Lenard, C Lázaro.   

Abstract

Neurofibromas are one of the most characteristic features of neurofibromatosis type 1 (NF1), an inherited autosomal-dominant neurogenetic disorder affecting 1 in 3500 individuals worldwide. These benign tumors mainly consist of Schwann cells (SCs) and fibroblasts. Recent evidence demonstrates that somatic mutations at the NF1 gene are found in neurofibromas, but it has not been demonstrated whether SCs, fibroblasts and/or both cell types bear a somatic loss of NF1. We recently established a cell culture system that allows selective expansion of human SCs from neurofibromas. We cultured pure populations of SCs and fibroblasts derived from 10 neurofibromas with characterized NF1 mutations and found that SCs but not fibroblasts harbored a somatic mutation at the NF1 locus in all studied tumors. Furthermore, by culturing neurofibroma-derived SCs under different in vitro conditions we were able to obtain two genetically distinct SC subpopulations: NF1(-/-) and NF1(+/-). These data strongly support the idea that NF1 mutations in SCs, but not in fibroblasts, correlate to neurofibroma formation and demonstrate that only a portion of SCs in neurofibromas have mutations in both NF1 alleles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115850     DOI: 10.1093/hmg/9.20.3055

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  66 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

2.  An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.

Authors:  Karlyne M Reilly; Karl W Broman; Roderick T Bronson; Shirley Tsang; Dagan A Loisel; Emily S Christy; Zhonghe Sun; John Diehl; David J Munroe; Robert G Tuskan
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells.

Authors:  Nancy M Joseph; Yoh-Suke Mukouyama; Jack T Mosher; Martine Jaegle; Steven A Crone; Emma-Louise Dormand; Kuo-Fen Lee; Dies Meijer; David J Anderson; Sean J Morrison
Journal:  Development       Date:  2004-10-20       Impact factor: 6.868

4.  The development of cutaneous neurofibromas.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Tom Callens; Elina Jokinen; Anthony M Heape; Ludwine Messiaen; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.

Authors:  Paula Pennanen; Sirkku Peltonen; Roope A Kallionpää; Juha Peltonen
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

Review 6.  Mosaic RASopathies.

Authors:  Christian Hafner; Leopold Groesser
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

7.  NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.

Authors:  Simona Parrinello; Luke A Noon; Marie C Harrisingh; Patrick Wingfield Digby; Laura H Rosenberg; Catherine A Cremona; Pedro Echave; Adrienne M Flanagan; Luis F Parada; Alison C Lloyd
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

Review 8.  Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.

Authors:  Philip D King; Beth A Lubeck; Philip E Lapinski
Journal:  Sci Signal       Date:  2013-02-26       Impact factor: 8.192

9.  Neurofibromatosis and lessons for the war on cancer.

Authors:  Karlyne M Reilly
Journal:  EMBO Mol Med       Date:  2009-07       Impact factor: 12.137

10.  Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.

Authors:  S J Miller; Z D Lan; A Hardiman; J Wu; J J Kordich; D M Patmore; R S Hegde; T P Cripe; J A Cancelas; M H Collins; N Ratner
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.